DWA
CSTL icon

Dorsey Wright & Associates’s Castle Biosciences CSTL Stock Holding History

Dorsey Wright & Associates’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-618
Closed -$42.3K – 311
2021
Q1 		$42.3K Buy
618
+354
+134% +$26.6K 0.5% 82
2020
Q4 		$18K Buy
264
+66
+33% +$3.58K ﹤0.01% 187
2020
Q3 		$10K Sell
198
-66
-25% -$2.94K ﹤0.01% 192
2020
Q2 		$10K Buy
+264
New +$9.02K ﹤0.01% 242

Other funds holding CSTL

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PM
Pembroke Management Montreal, Quebec, Canada $691M AUM 27.96% 1-Year Est. Return

Dorsey Wright & Associates's CSTL Position: Q2 2021 in Review

Dorsey Wright & Associates sold out of Castle Biosciences (CSTL) in Q2 2021, closing a stake of 618 shares — an estimated $42.3K sold.

Dorsey Wright & Associates first reported a position in CSTL in Q2 2020 and held it in 4 quarters. The position peaked at $42.3K in Q1 2021. 181 funds tracked by Wall St. Rank hold CSTL as of Q2 2021.

  • Dorsey Wright & Associates reported no remaining Castle Biosciences position as of Q2 2021 after selling out during the quarter.
  • Dorsey Wright & Associates sold 618 Castle Biosciences shares in Q2 2021, an estimated $42.3K.
  • Dorsey Wright & Associates first reported a position in Castle Biosciences in Q2 2020 and held it in 4 quarters.
  • Dorsey Wright & Associates's Castle Biosciences position peaked at $42.3K in Q1 2021.
  • 181 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2021.

Based on Dorsey Wright & Associates's 13F filing for Q2 2021, filed 23 Jul 2021.